相关实验视频
Updated: Jul 11, 2025

08:12
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
3.1K
晶体包装揭示了潜在的自抑制KRAS调光器接口和RAS信号的小分子抑制策略
Robert J Brenner1, Alexander D Landgraf1, Khuchtumur Bum-Erdene1
1Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States.
Biochemistry
|November 8, 2023
概括
研究人员发现了一种新的KRAS G12D蛋白质结构,形成一种可用药物的接口. 这一发现提供了一种新的策略,通过向这种自我抑制的形状来抑制癌症中的RAS信号传递.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 在瘤学瘤学.
背景情况:
- 在人类癌症中,KRAS GTPases经常发生突变,导致瘤生长.
- 由于缺乏明确的小分子结合部位,克拉斯是众所周知的难以药物.
研究的目的:
- 为了研究KRAS G12D的结构基础.
- 为了确定KRAS上潜在的可用药物的部位,用于癌症治疗.
主要方法:
- 他标记的KRAS G12D的X射线晶体学.
- 氨酸扫描突变发生.
- 化学自由能量扰动计算.
- 显式溶剂分子动力学模拟.
主要成果:
- 一个独特的晶体结构揭示了KRAS G12D的形状变化,形成了一个类似蛋白质的蛋白质接口.
- 关键接口氨基酸被确定为热点,对相互作用做出了重大贡献.
- 计算分析在复杂结构中发现了两个大,可用药物的口袋.
结论:
- 已识别的接口和口袋代表了KRAS的新型,潜在的可药性构造.
- 针对这种自我抑制的KRAS结构可能为具有KRAS突变的癌症提供新的治疗策略.
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K

